Gaspoz Jean-Michel
Division of Primary Care Medicine; Chairman, Department of Community Medicine, Primary Care and Emergency Medicine, University Hospitals, Geneva, Switzerland.
Swiss Med Wkly. 2015 Mar 26;145:w14125. doi: 10.4414/smw.2015.14125. eCollection 2015.
Echoing the "less is more" and "choosing wisely" campaigns in the USA, the "smarter medicine" campaign launched in 2014 by the Swiss Society of General Internal Medicine listed five tests or treatments that are often prescribed in ambulatory general internal medicine, but that may not provide any meaningful benefit and may carry the risk of generating harms and costs. In the United Kingdom, the National Institute for Health and Care Excellence (NICE) supported the National Health Services in identifying "low value" activities that should be stopped. Political pressure and stringent regulatory measures for pharmaceuticals and medical technology triggered major controversy and opposition. NICE efforts now concentrate on editing guidelines based on consensus techniques, which integrate the evidence from systematic reviews with social values and patient preferences. To obtain significant changes and promote the paradigm of reducing unnecessary waste of medical resources, opinion leaders and leading scientific or academic institutions, as well as medical societies, can make a difference, together with consumer associations and the lay press. Politicians can undoubtedly contribute to the success of these strategies, but rather than putting physicians alone under pressure and setting up stringent regulatory measures, they should network with all stakeholders and put emphasis on a broader agenda, the one of improving healthcare quality and efficiency.
与美国的“少即是多”和“明智选择”运动相呼应,瑞士普通内科医学协会于2014年发起的“更明智的医学”运动列出了五项在门诊普通内科中经常开具的检查或治疗项目,这些项目可能不会带来任何有意义的益处,反而可能带来伤害和成本风险。在英国,国家卫生与临床优化研究所(NICE)支持国民医疗服务体系识别应停止的“低价值”活动。针对药品和医疗技术的政治压力及严格监管措施引发了重大争议和反对。NICE目前的工作重点是基于共识技术编辑指南,将系统评价的证据与社会价值观和患者偏好相结合。为实现重大变革并推动减少医疗资源不必要浪费的模式,意见领袖、领先的科学或学术机构以及医学协会,与消费者协会和大众媒体携手合作可以发挥作用。政治家无疑能为这些战略的成功做出贡献,但他们不应只给医生施压并制定严格的监管措施,而应与所有利益相关者建立联系,强调更广泛的议程,即提高医疗质量和效率的议程。